PVI
GILD icon

Pura Vida Investments’s Gilead Sciences GILD Stock Holding History

Pura Vida Investments’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100,000
Closed -$5.95M – 233
2022
Q1 		$5.95M Buy
+100,000
New +$6.39M 0.19% 112

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pura Vida Investments's GILD Position: Q2 2021 in Review

Pura Vida Investments sold out of Gilead Sciences (GILD) in Q2 2021, closing a stake of 50,602 shares — an estimated $3.27M sold.

Pura Vida Investments first reported a position in GILD in Q4 2014 and held it in 7 quarters. The position peaked at $9.51M in Q3 2019. 1,545 funds tracked by Wall St. Rank hold GILD as of Q2 2021.

  • Pura Vida Investments reported no remaining Gilead Sciences position as of Q2 2021 after selling out during the quarter.
  • Pura Vida Investments sold 50,602 Gilead Sciences shares in Q2 2021, an estimated $3.27M.
  • Pura Vida Investments first reported a position in Gilead Sciences in Q4 2014 and held it in 7 quarters.
  • Pura Vida Investments's Gilead Sciences position peaked at $9.51M in Q3 2019.
  • 1,545 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2021.

Based on Pura Vida Investments's 13F filing for Q2 2021, filed 16 Aug 2021.